Ovarian Stimulation Protocols by Gautam N. Allahbadia & Yoshiharu Morimoto

Author:Gautam N. Allahbadia & Yoshiharu Morimoto
Language: eng
Format: epub
Publisher: Springer India, New Delhi

Conclusion

A similar biological or “biosimilar” medicine is a biological medicine that is similar to another biological medicine that has already been authorized for use. Biological medicines are medicines that are made by or derived from a biological source, such as a bacterium or yeast. They can consist of relatively small molecules, such as human insulin or erythropoietin, or complex molecules such as monoclonal antibodies. Owing to affordability and easy accessibility, biosimilars have established a good reputation among healthcare professionals. Though biosimilars are gaining popularity in national and international markets, it is important to remember that the biosimilars are not biological generics. These are rather unique molecules which are supported by only limited clinical data at the time of approval [15]. Therefore, there are concerns regarding their efficacy, long-term safety, and immunogenicity. At present, India is one of the leading contributors in the world biosimilar market. India has demonstrated the greatest acceptance of biosimilars, which is reflected from over 50 biopharmaceutical brands getting marketing approval [16]. The Indian biotechnology industry is also gaining momentum, with revenues of over US $2.0 billion reported in 2006, 70 % of which were biopharmaceuticals [17, 18]. According to a report, published in May 2014, by Visiongain, a business information publisher and consultancy in London, the world market drug revenues for biosimilars and related follow-on biologics will reach $9.2bn in 2018, and multiply in size to 2024, the fastest growth expected to be experienced within the submarkets for biosimilar monoclonal antibodies (mAbs) and insulins [19].

Download

Copyright Disclaimer:
This site does not store any files on its server. We only index and link to content provided by other sites. Please contact the content providers to delete copyright contents if any and email us, we'll remove relevant links or contents immediately.